A threshold-based reward gives a molecule optimization feedback only after it meets specified minimum or maximum property values. This turns several drug-design requirements into joint gates rather than allowing one excellent property to compensate for a failure elsewhere. section 13.3.1
Drug-design thresholds
A candidate receives zero reward unless IC50 is below 100 nM, solubility exceeds 10 µM, and synthetic accessibility exceeds 0.5. The approach guarantees these constraints but provides no gradient signal while properties remain far from their thresholds, which can slow early learning. section 13.3.1
Use threshold-based rewards when:
- Hard requirements matter more than trade-offs among normalized property scores. section 13.3.1
- Structural constraints such as molecular weight, chiral-center count, or scaffold presence must be enforced separately. section 13.3.1
